We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTR icon
51
Nutrien
NTR
$33.9B
$10.8M 0.28%
183,410
-50
-0% -$3.18K
VZ icon
52
Verizon
VZ
$197B
$10.5M 0.27%
282,907
-6,887
-2% -$255K
TSQ icon
53
Townsquare Media
TSQ
$105M
$8.86M 0.23%
743,713
+58,752
+9% +$573K
FDX icon
54
FedEx
FDX
$73B
$8.8M 0.23%
35,498
-1,068
-3% -$244K
PG icon
55
Procter & Gamble
PG
$340B
$8.11M 0.21%
53,442
-1,034
-2% -$156K
KMB icon
56
Kimberly-Clark
KMB
$37.6B
$7.52M 0.2%
54,448
-1,300
-2% -$181K
XOM icon
57
ExxonMobil
XOM
$650B
$5.92M 0.15%
55,160
-429
-0.8% -$46.8K
DIBS icon
58
1stdibs.com
DIBS
$148M
$5.61M 0.15%
1,500,814
+175,997
+13% +$670K
COST icon
59
Costco
COST
$432B
$5.47M 0.14%
10,168
– –
ARES icon
60
Ares Management
ARES
$28.1B
$5.17M 0.14%
53,610
+1,430
+3% +$124K
TCN
61
DELISTED
Tricon Residential Inc.
TCN
$5.16M 0.13%
585,491
+79,009
+16% +$646K
VTS icon
62
Vitesse Energy
VTS
$644M
$5.15M 0.13%
229,930
-12,664
-5% -$264K
LUMN icon
63
Lumen
LUMN
$6.43B
$4.97M 0.13%
2,201,251
-80,417
-4% -$177K
HD icon
64
Home Depot
HD
$337B
$4.82M 0.13%
15,531
-2,908
-16% -$859K
ABBV icon
65
AbbVie
ABBV
$465B
$4.53M 0.12%
33,638
-1,925
-5% -$282K
BAM icon
66
Brookfield Asset Management
BAM
$75.6B
$4.26M 0.11%
130,636
-12,659
-9% -$407K
PEP icon
67
PepsiCo
PEP
$196B
$4.2M 0.11%
22,662
– –
BRK.A icon
68
Berkshire Hathaway Class A
BRK.A
$1.1T
$4.14M 0.11%
8
– –
KKR icon
69
KKR & Co
KKR
$89.1B
$4.04M 0.11%
72,142
-25
-0% -$1.31K
PFE icon
70
Pfizer
PFE
$143B
$3.39M 0.09%
92,462
– –
MTB icon
71
M&T Bank
MTB
$36.3B
$3.25M 0.08%
26,233
-760
-3% -$92K
BAX icon
72
Baxter International
BAX
$12.8B
$3.15M 0.08%
69,245
-4,500
-6% -$196K
AXS icon
73
AXIS Capital
AXS
$7.81B
$3.04M 0.08%
56,531
-1,700
-3% -$92.9K
DHR icon
74
Danaher
DHR
$138B
$2.91M 0.08%
13,660
-73
-0.5% -$15.5K
PGR icon
75
Progressive
PGR
$128B
$2.76M 0.07%
20,885
-1,135
-5% -$152K
1 2
3
4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.